blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1448762

EP1448762 - ANTISENSE MODULATION OF TOLL-LIKE RECEPTOR 4 EXPRESSION FIELD OF THE INVENTION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.10.2005
Database last updated on 26.06.2024
Most recent event   Tooltip14.10.2005Application deemed to be withdrawnpublished on 30.11.2005  [2005/48]
Applicant(s)For all designated states
Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010 / US
[N/P]
Former [2005/26]For all designated states
Isis Pharmaceuticals, Inc.
1896 Rutherford Road
Carlsbad, CA 92008 / US
Former [2004/35]For all designated states
ISIS PHARMACEUTICALS, INC.
2292 Faraday Avenue
Carlsbad, CA 92008 / US
Inventor(s)01 / KARRAS, James, G.
1159 Montura Road
San Marcos, CA 92069 / US
02 / KOLLER, Erich
2622 Lewis Lane
Carlsbad, CA 92008 / US
 [2004/35]
Representative(s)Bassil, Nicholas Charles, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2004/35]Bassil, Nicholas Charles, et al
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date02797100.114.11.2002
[2004/35]
WO2002US36390
Priority number, dateUS2001000186319.11.2001         Original published format: US 1863
[2004/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03044163
Date:30.05.2003
Language:EN
[2003/22]
Type: A2 Application without search report 
No.:EP1448762
Date:25.08.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 30.05.2003 takes the place of the publication of the European patent application.
[2004/35]
Search report(s)International search report - published on:US15.04.2004
(Supplementary) European search report - dispatched on:EP04.03.2005
ClassificationIPC:C12N5/00, C12Q1/68, A61K31/70, C07H21/04
[2005/15]
CPC:
C12N15/1138 (EP,US); A61K38/00 (EP,US); C12N2310/315 (EP,US);
C12N2310/321 (EP,US); C12N2310/3341 (EP,US); C12N2310/341 (EP,US);
C12N2310/346 (EP,US); Y02P20/582 (EP,US) (-)
C-Set:
C12N2310/321, C12N2310/3525 (EP,US)
Former IPC [2004/35]C12N5/00, C12Q1/68, A61K31/70, A01N43/04, C07H21/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/35]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ANTISENSE-MODULATION DER EXPRESSION DES TOLL-ÄHNLICHEN REZEPTORS 4 ERFINDUNGSGEBIET[2004/35]
English:ANTISENSE MODULATION OF TOLL-LIKE RECEPTOR 4 EXPRESSION FIELD OF THE INVENTION[2004/35]
French:MODULATION ANTISENS DE L'EXPRESSION D'UN RECEPTEUR 4 DE TYPE TOLL[2004/35]
Entry into regional phase28.05.2004National basic fee paid 
28.05.2004Search fee paid 
28.05.2004Designation fee(s) paid 
28.05.2004Examination fee paid 
Examination procedure12.06.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
28.05.2004Amendment by applicant (claims and/or description)
28.05.2004Examination requested  [2004/35]
19.05.2005Application deemed to be withdrawn, date of legal effect  [2005/48]
30.06.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2005/48]
Fees paidRenewal fee
28.05.2004Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0172993  (MOCHIDA PHARM CO LTD [JP], et al) [X] 1-20 * SEQ ID NO.8 has 100% identity in a 20nt overlap to SEQ ID NO.11 of the present application *;
 [E]WO03035110  (CEDARS SINAI MEDICAL CENTER [US]) [E] 1-20* Sequence 4 has 100% identity in a 16nt overlap to SEQ ID NO.23 of the present application *;
 [Y]  - SMITH P D ET AL, "Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 SEP 2001, (20010901), vol. 167, no. 5, ISSN 0022-1767, pages 2651 - 2656, XP002316199 [Y] 1-20 * page 2652, column L, paragraph 4 *
 [Y]  - KOLLER E ET AL, "Elucidating cell signaling mechanisms using antisense technology", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, (200004), vol. 21, no. 4, ISSN 0165-6147, pages 142 - 148, XP004196016 [Y] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0165-6147(00)01448-6
 [Y]  - HEDLUND M ET AL, "Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells.", MOLECULAR MICROBIOLOGY. FEB 2001, (200102), vol. 39, no. 3, ISSN 0950-382X, pages 542 - 552, XP002316200 [Y] 1-20 * page 550, column R; table 2 *

DOI:   http://dx.doi.org/10.1046/j.1365-2958.2001.02205.x
 [A]  - BAKER B F ET AL, "Discovery and analysis of antisense oligonucleotide activity in cell culture.", METHODS (SAN DIEGO, CALIF.) FEB 2001, (200102), vol. 23, no. 2, ISSN 1046-2023, pages 191 - 198, XP002316201

DOI:   http://dx.doi.org/10.1006/meth.2000.1120
 [A]  - HAO H ET AL, "Human beta-defensin-2 production by lipopolysaccharide treated-astrocytes depends on toll-like receptor expression", SOCIETY FOR NEUROSCIENCE ABSTRACTS, & 31ST ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE; SAN DIEGO, CALIFORNIA, USA; NOVEMBER 10-15, 2001, (2001), vol. 27, no. 2, ISSN 0190-5295, page 1757, XP001205207
 [A]  - HOSHINO K ET AL, "Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, (19990401), vol. 162, no. 7, ISSN 0022-1767, pages 3749 - 3752, XP002221244
International search[X]WO0077204  (UNIV IOWA RES FOUND [US], et al);
 [X]  - QURESHI ET AL., "Endotoxin-tolerant mice have mutatons in toll-like receptor 4 (Tlr4)", JOURNAL OF EXPERIMENTAL MEDICINE, (19990215), vol. 189, no. 4, pages 615 - 625, XP000900609

DOI:   http://dx.doi.org/10.1084/jem.189.4.615
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.